Table 1.
Baseline patient characteristics
| Patient characteristics (n = 628) | ||
|---|---|---|
| Median Age at inclusion (IQR) | 65 | (17) |
| Gender f (%) | ||
| Female | 359 | (57) |
| Male | 269 | (43) |
| Geographical region f (%) | ||
| Europe | 578 | (92) |
| Canada | 43 | (7) |
| Australia | 7 | (1) |
| Cancer type f (%) | ||
| Low risk cancer | 184 | (29) |
| Breast | 171 | (27) |
| Haematological | 13 | (2) |
| Neutral risk cancer | 410 | (65) |
| Lung | 125 | (20) |
| Colorectal | 70 | (11) |
| Prostate | 48 | (8) |
| Female genitalia | 36 | (6) |
| Head and neck | 24 | (5) |
| Urinary | 20 | (3) |
| Hepatobiliary | 17 | (3) |
| Sarcoma, connective and soft tissue | 17 | (3) |
| Small intestine | 11 | (2) |
| Oesophageal | 8 | (1) |
| Other | 34 | (5) |
| High risk cancer | 33 | (5) |
| Pancreatic | 24 | (4) |
| Gastric | 9 | (1) |
| Cancer stage f (%) | ||
| Local | 83 | (13) |
| Metastatic/disseminated | 543 | (87) |
| Treatment setting | ||
| Inpatients | 56 | (9) |
| Outpatients | 483 | (78) |
| Home care | 77 | (13) |
| Anti-cancer treatment | ||
| Chemotherapy | 337 | (54) |
| Hormonal therapy | 81 | (13) |
| Radiotherapy | 35 | (6) |
| Other | 47 | (7) |
| No treatment | 173 | (28) |
| Median Karnofsky PS (IQR) | 70 | (10) |
| Weight loss (6 months) f (%) | ||
| < 1% | 535 | (85) |
| 1–5% | 93 | (15) |
| Mean BMI (SD) | 25.5 | (4.5) |
| Comorbidities f (%) | ||
| Heart disease | 165 | (26) |
| COPD | 62 | (10) |
| Arthritis | 51 | (8) |
| Renal disease | 17 | (3) |
Abbreviations: IQR interquartile range, PS performance status, SD standard deviation, COPD chronic obstructive pulmonary disease